HealthMore in Health →
Kidney disease drug development is finally building a deeper bench
After years of limited treatment options, kidney disease research is moving into a more active phase, with targeted therapies ranging from immunomodulators to genetically defined drugs.
Key Takeaways
- Nature Medicine says kidney disease is seeing a surge of targeted therapies after years of limited options.
- The emerging pipeline includes immunomodulators and genetically defined drugs.
DE
DT Editorial AI··via nature.com